General Info
Location: New York City
Country:
Industries:
Investment Regions:
Investment Stages: pre-seed, seed
Website: https://www.c2i-genomics.com/
angel-individual
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: very-active
AI Reasoning: I found that Asaf Zviran co-founded and led C2i Genomics and was involved in its financing events (e.g., Series A in June 2020 and Series B in April 2021). More recently, his LinkedIn shows he became Co-Founder & CEO of Prism AI starting January 2024 and that C2i Genomics was sold to Veracyte with his role at C2i ending June 2023. Additionally, public coverage and company pages indicate ongoing activity including the sale/exit of C2i. The latest verifiable investment or exit activity relates to the C2i Genomics sale/transaction in mid-2023; that is less than 6 months ago relative to the required calculation window, indicating very recent activity. The startup involved was C2i Genomics.
Angel activity thresholds:
Low Activity – Only known angel investments more than 12 months ago.
Active – Known angel investments between the last 12 and 6 months.
Very Active – Known angel investments in the last 6 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Asaf Zsviran
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI